|
Facebook
Twitter
Linkedin
|
About MDS Nordion
MDS Nordion, a business unit of MDS Inc., is a global leader in providing medical isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies for medical products. MDS Nordion products and services are used on a daily basis by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. MDS Inc. is a global life sciences company that provides market-leading products and services that customers need for the development of drugs, and the diagnosis and treatment of disease. MDS Nordion is one of three business units that make up MDS Inc. The other two core business are MDS Analytical Technologies and MDS Pharma Services.
MDS Nordion Details
Company Name
MDS NordionAddress
447 March Rd., Ottawa, ON, Canada, K2K 1X8Headquarters City
CanadaCompany Type
Public (TSX: MDS), (NYSE: MDZ)Founded
1969Country of Incorporation
USAPresident
Steve WestMDS Nordion News
- MDS Nordion Named for Second Straight Year as One of Canada's Top 100 Employers
- MDS Nordion Appoints Kenneth Newport to its Board of Directors
- MDS Nordion Secures Cobalt-60 Supply Agreement with Ontario Power Generation until 2020
- MDS Nordion Announces Changes to the Board
- MDS Nordion's TheraSphere Highlighted at SIR10
- MDS Nordion Selected One of Canada’s Top 100 Employers for 2010
- MDS Nordion Collaborates With Karpov Institute of Physical Chemistry to Develop Molybdenum-99
- MDS Nordion Begins to Manufacture Cardiac Imaging Agent
- MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
- MDS Nordion, TRIUMF, and the University of British Columbia Announce Partnership
775








